Importantly, the role of CD81 in tumor development seems multifaceted with suppressive as well as protooncogenic functions (Vences-Catalán et al., 2017) and could be dependent on the tumor type as well as co-factors, for instance an ongoing HCV-infection that interferes with innate immune signaling in hepatocytes. The gene discussed is CD81; the disease is neoplasm.